(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

OLIGONUCLEOTÍDEOS PARA MODULAÇÃO DE SNCA

Em AnáliseInvention PatentPCT · US2021022748

Application data

Number

112022018475

Type

Invention Patent

Filing

03/17/2021

Publication

11/29/2022

PCT

US2021022748

Progress at the INPI

  1. Filing03/17/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 03/17/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/29/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

U. M. (pessoa física)

US

See this company's full portfolio

Inventors

A. K. (pessoa física)

US

C. F. (pessoa física)

US

K. M. (pessoa física)

US

S. D. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/991,406 · 03/18/2020

US

63/071,115 · 08/27/2020

Abstract

OLIGONUCLEOTÍDEOS PARA MODULAÇÃO DE SNCA. Esta divulgação se refere a novas sequências de alvo de SNCA. Novos oligonucleotídeos direcionados a SNCA para o tratamento de doenças neurodegenerativas também são fornecidos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

11/29/2022

RPI 2708

Alteração de dados cadastrais

#1.1

09/27/2022

RPI 2699

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.